Table 2 Serum NDKA levels in the screening cohort according to the colorectal findings.
From: Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer
Colorectal findings | N | Median (pg/mL) | IQR (pg/mL) | P |
|---|---|---|---|---|
No neoplasia | 334 | 56.90 | 46.88–66.94 | |
No colorectal findings | 173 | 57.37 | 46.88–69.11 | |
Benign pathologies | 161 | 56.19 | 46.86–65.44 | 0.542b |
Inflammatory Polyps | 5 | 55.24 | 49.00–71.27 | 0.944b |
Hyperplasic Polyps | 39 | 55.05 | 42.21–65.00 | 0.218b |
Haemorrhoids | 67 | 55.43 | 47.14–64.51 | 0.338b |
Diverticula | 44 | 60.70 | 47.26–71.76 | 0.472b |
Other | 6 | 60.39 | 46.48–83.07 | 0.548b |
Non-advanced adenomas | 120 | 58.34 | 45.12–71.06 | 0.499a |
Advanced neoplasia | 57 | 66.93 | 47.54–82.49 | 0.006a |
Advanced adenomas | 53 | 66.93 | 47.54–82.49 | 0.010a |
Cancer | 4 | 66.98 | 49.18–91.81 | 0.262a |
